Business Insider got a tour of Rivian's lab in Palo Alto, where the EV maker's pivot to AI-defined vehicles began and will ...
“The clinical value of ProFound AI Risk is unparalleled, and this exciting research adds to the growing body of evidence that confirms iCAD’s technology is not only more personalized than traditional ...
TORONTO, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, ...
NASHUA, N.H., April 20, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc (ICAD). (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced new ...
Company’s year-end TULSA-PRO installed base stood at 78 systems; qualified sales pipeline grew to 97 new systemsTORONTO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ...
NASHUA, N.H., July 15, 2020 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced ProFound AI™ ...
Strategic alliance combines iQuanti's data-driven marketing expertise with Profound's AI visibility intelligence to help brands capitalize on the AI Search revolution The partnership integrates ...
Strategic alliance combines iQuanti's data-driven marketing expertise with Profound's AI visibility intelligence to help brands capitalize on the AI Search revolution JERSEY CITY, N.J., Dec. 1, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback